Watch Dr. Keith Vossel's live interview on July 7th, with KCAL-LA Morning News, about the benefits of the treatment, possible side effects, and expected out-of-pocket costs with CMS coverage for patients eligible for Leqembi, a fully FDA-approved Alzheimer’s drug.
